Steroid-eluting stents in patients with acute coronary syndromes. angiographic results of DESIRE: Dexamethasone-eluting stent italian registry

Journal of Invasive Cardiology

Volumn 21, Issue 3, 2009, Pages 86-91

  Pesarini, Gabriele ^a   Ferrero, Valeria ^a   Tomai, Fabrizio ^b   Paloscia, Leonardo ^c   De Cesare, Nicoletta ^d   Tamburino, Corrado ^e   Piscione, Federico ^f   Vassanelli, Francesca ^a   Ribichini, Flavio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b EUROPEAN HOSPITAL   (Italy)

^c SPIRITO SANTO HOSPITAL   (Italy)

^d Policlinico San Marco   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DEXAMET; DEXAMETHASONE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; TROPONIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; LABORATORY TEST; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; ST SEGMENT; ST SEGMENT ELEVATION; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DEXAMETHASONE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 67649580217     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2007;50:e1-e157.a
2. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-715.
3. Cannon C P, Weintraub WS, Demopoulos LA, et al, for the TACTIS-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
4. Fox KA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: The British Heart Foundation RITA 3 randomised trial. Lancet 2005;366:914-920.
5. Lagerqvist B, Husted S, Kontny F, et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: A follow-up study. Lancet 2006;368:998-1004.
6. Moses J W, Mehran R, Nikolsky EG, et al. Outcomes with the paclitaxel eluting stent in patients with acute coronary syndromes. J Am Coll Cardiol 2005;45:1165-1171.
7. Weisz G, Moses JW, Teirstein PS, et al. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). Am J Cardiol 2007;99:1044-1150.
8. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-250.
9. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992;326:310-318.
10. Versaci F, Gaspardone A, Tomai F, et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 2002;40:1935-1942.
11. Ribichini F, Tomai F, Ferrero V, et al. Immunosuppressive oral prednisone after percutaneous interventions in patients with multivessel coronary artery disease. The IMPRES-2/MVD study. Eurointervention 2005;2:173-180.
12. Ribichini F, Ferrero V, Rognoni A, et al. Percutaneous treatment of coronary bifurcations: Lesion preparation before provisional bare metal stenting and subsequent im-munosuppression with oral prednisone. The IMPRESS-Y Study. J Intervent Cardiol 2007;20:114-121.
13. Ferrero V, Ribichini F, Rognoni A, et al. Comparison of efficacy and safety of lowered-dose to higher-dose oral prednisone after percutaneous coronary intervention. The IM-PRESS-LD Study. Am J Cardiol 2007;99:1082-1086.
14. Ferrero V, Ribichini F, Pesarini G, et al. Therapeutic potential of glucocorticoids in the prevention of restenosis after coronary angioplasty. Drugs 2007;67:1243-1155.
15. Ribichini F, Joner M, Ferrero V, et al. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol 2007;50:176-185.
16. Ribichini F, Tomai F, Paloscia L, et al for the DESIRE investigators. Steroid-eluting stents in patients with acute coronary syndromes. The DESIRE: Dexamethasone Elut-ing Stent Italian REgistry. Heart 2007;93:598-600.
17. Hamm CW, Braunwald E. A classification of unstable angina pectoris revisited. Circulation 2000;102:118-122.
18. Sabatine SM, Morrow DA, Cannon C P, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes - A TACTICS-TIMI 18 substudy. J Am Coll Cardiol 2002;40:1761-1768.
19. Popma JJ, Bashore TD. Quantitative angiography. In: Topol EJ (ed). Textbook of Interventional Cardiology. Philadelphia (PA): WB Saunders. 1994, pp. 1052-1068.
20. Liu X, Huang Y, Hanet C, et al. Study of antirestenosis with the BiodivYsio dexam-ethasone-eluting stent (STRIDE): A first-in-human multicenter pilot trial. Catheter Cardiovasc Interv 2003;60:172-178.
21. Hoffmann R, Langenberg R, Radke P, et al. Evaluation of a high-dose dexamethasoneeluting stent. Am J Cardiol 2004;94:193-195.
22. Hoffmann R, Radke PW, Ortlepp JR, et al. Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries. Am J Cardiol 2004;94:1548-1550.
23. Han SH, Ahn TH, Kang WC, et al. The favorable clinical and angiographic outcomes of a high-dose dexamethasone dexamethasone-eluting stent: Randomised controlled prospective study. Am Heart J 2006;152:887e1-e7.
24. Konig A, Leibig M, Reiber J, et al. Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: Serial angiographic and sonographic analysis. Am Heart J 2007;153:979e1-e8.
25. Hausleiter J, Kastrati A, Wessely R, et al. Prevention of restenosis by a novel drugeluting stent system with a dose-adjustable, polymer-free, on-site stent coating. Eur Heart J 2005;26:1475-1481.
26. Mehilli J, Kastrati A, Wessely R, et al. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 2006;113:273-279.